The analysis identified IL‐17, MIP‐1α, and MCP‐3 as being causally linked to an increased risk of bipolar disorder, highlighting their potential roles in the disease etiology and offering promising targets for future therapeutic strategies. This evidence concerns the gene IL17A and bipolar disorder.